Healthcare Industry News: RaySearch Laboratories
News Release - April 23, 2012
RaySearch Laboratories: Hallym University Medical Center selects RayStation(R)STOCKHOLM--(Healthcare Sales & Marketing Network)--RaySearch Laboratories AB (STO:RAYB) has received an order for its RayStation® treatment planning system from Hallym University Medical Center in Seoul, South Korea.
Hallym University Medical Center (HUMC), one of the largest medical institutions in Korea, consists of six general hospitals: Hallym University Sacred Heart Hospital, Hallym University Hangang Sacred Heart Hospital, Hallym University Kangnam Sacred Heart Hospital, Hallym University Chuncheon Sacred Heart Hospital, Hallym University Dongtan Sacred Heart Hospital and Hallym University Kangdong Sacred Heart Hospital. HUMC operates 3,200 patient-beds at its hospitals with 6,000 employees including 500 medical professors.
HUMC will initially use RayStation® as its treatment planning system at Hallym University Sacred Heart Hospital and Hallym University Dongtan Sacred Heart Hospital for conventional 3D-CRT treatments, as well as more advanced treatments, such as IMRT and VMAT. Alongside the treatment planning and optimization components, the order also encompasses a fully integrated package of image processing tools such as automated organ segmentation and image fusion.
“This is the second order from South Korea and the first for treatment planning for conventional radiation therapy. I think this order is yet another sign of the interest RayStation® is generating his on all markets where we are active. We are looking forward to work together with our distributor OTS to introduce RayStation® as quickly as possible at Hallym University Medical Center ”, says Johan Löf, CEO of RaySearch.
RayStation® integrates all RaySearch’s advanced treatment planning solutions into a flexible treatment planning system. It combines unique features such as multi-criteria optimization tools with full support for 4D adaptive radiation therapy. It also includes functionality such as RaySearch’s market-leading algorithms for IMRT and VMAT optimization and highly accurate dose engines for both photon and proton therapy. The system is built on the latest software architecture and has a graphical user interface offering state-of-the-art usability.
RaySearch Laboratories is a medical technology company that develops advanced software solutions for improved radiation therapy of cancer. RaySearch’s products are mainly sold through license agreements with leading partners such as Philips, Nucletron, IBA Dosimetry, Varian, Accuray and Siemens. To date, 15 products have been launched through partners and RaySearch’s software is used at some 1,800 clinics in more than 30 countries. In addition, RaySearch offers the proprietary treatment planning system RayStation® directly to clinics. RaySearch was founded in 2000 as a spin-off from Karolinska Institutet in Stockholm and the company is listed in the Small Cap segment on NASDAQ OMX Stockholm.
For more information about RaySearch, visit www.raysearchlabs.com
Source: RaySearch Laboratories
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.